Ailomics Therapeutics
Shanghai
About Ailomics Therapeutics
Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors. Ailomics Therapeutics was founded in 2022 and was headquartered in Shanghai, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Angel (May 2023)
- Website: ailomics.com
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ailomics-therapeutics-3190790 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.